WEC
WST icon

Winslow Evans & Crocker’s West Pharmaceutical WST Stock Holding History

Winslow Evans & Crocker’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$375K Sell
1,325
-175
-12% -$49.1K 0.07% 229
2020
Q3 		$412K Buy
1,500
+75
+5% +$19.8K 0.1% 191
2020
Q2 		$324K Buy
+1,425
New +$280K 0.09% 217
2019
Q2 		– Sell
-24
Closed -$4K – 1351
2019
Q1 		$4K Buy
+24
New +$2.5K ﹤0.01% 1062
2016
Q3 		– Sell
-4,426
Closed -$336K – 1322
2016
Q2 		$336K Buy
+4,426
New +$322K 0.1% 199

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Winslow Evans & Crocker's WST Position: Q4 2020 in Review

Winslow Evans & Crocker reduced its West Pharmaceutical (WST) stake by 12% in Q4 2020, selling an estimated $49.1K and leaving 1,325 shares worth $375K. The position accounts for 0.07% of the portfolio, ranked #229.

Winslow Evans & Crocker first reported a position in WST in Q2 2016 and has held it in 5 quarters since. The position peaked at $412K in Q3 2020. 592 funds tracked by Wall St. Rank hold WST as of Q4 2020.

  • Winslow Evans & Crocker held 1,325 shares of West Pharmaceutical worth $375K as of Q4 2020.
  • Winslow Evans & Crocker sold 175 West Pharmaceutical shares in Q4 2020, an estimated $49.1K.
  • West Pharmaceutical made up 0.07% of Winslow Evans & Crocker's portfolio in Q4 2020, its #229 holding.
  • Winslow Evans & Crocker first reported a position in West Pharmaceutical in Q2 2016 and has held it in 5 quarters since.
  • Winslow Evans & Crocker's West Pharmaceutical position peaked at $412K in Q3 2020.
  • 592 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.